Biomet expects to use the net proceeds of this offering to fund its tender offer for any and all of its outstanding 10⅜ / 11⅛ percent senior toggle notes due 2017, including related fees and expenses, and to purchase, redeem, defease or otherwise acquire or retire its outstanding indebtedness.
More Articles on Orthopedic Devices:
7 Biggest Factors Impacting Spine Research & Innovation
Wright Medical Group Slapped With Subpoena for Hip Device Documents
Alphatec Spine Reports 2Q Revenue of $48.2M, Down 5.2%
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
